Celgene, Takeda and Others Found in Breach of UK’s Pharma Code of Practice
By Zachary Brennan -
Published 14 March 2017
When is it OK for a pharmaceutical company to fail to quality check bags stored in a basement for three years before supplying them to pharmacies to use when dispensing the chemotherapy Navelbine (vinorelbine) to patients? Apparently never, according to Tuesday’s rundown of companies breaching the Association of British Pharmaceutical Industry’s (APBI) Code of Practice.
Categories: News, Europe, MHRA, Biologics and biotechnology, Compliance, Crisis management, Drugs, Ethics
Tags: Celgene, Takeda, Pierre Fabre, PMCPA, ABPI